Robert Wasserman
Stock Analyst at Benchmark Co.
(4.30)
# 1,392
Out of 4,792 analysts
231
Total ratings
46.8%
Success rate
11.5%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLFS BioLife Solutions | Downgraded: Hold | n/a | $34.93 | - | 11 | Aug 10, 2026 | |
| TLV: KMDA Kamada Ltd. | Reiterated: Buy | ILA 4,518 | ILA 2,490 | +81.46% | 5 | Jul 20, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $220 → $335 | $288.05 | +16.30% | 20 | Jul 16, 2026 | |
| RGEN Repligen | Upgraded: Buy | $185 | $165.05 | +12.09% | 11 | Jul 7, 2026 | |
| PRLB Proto Labs | Reiterated: Buy | $91 | $80.89 | +12.50% | 16 | Jul 6, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $72.25 | - | 18 | Jun 30, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $125.86 | -24.52% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $90 | $107.39 | -16.19% | 22 | Feb 19, 2026 | |
| CDXS Codexis | Reiterated: Hold | n/a | $1.43 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Reiterated: Buy | $6 → $4 | $4.02 | -0.37% | 11 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $4.02 | +832.84% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.05 | n/a | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.52 | n/a | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.68 | n/a | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.29 | n/a | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $4.50 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $605.69 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $204.85 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.01 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $80 | $1.99 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.63 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.54 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $3.64 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.2 | $6.50 | n/a | 1 | Oct 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $0.7998 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.4 | $2.14 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $0.93045 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.86 | n/a | 1 | Mar 12, 2013 |
BioLife Solutions
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $34.93
Upside: -
Kamada Ltd.
Jul 20, 2026
Reiterated: Buy
Price Target: ILA 4,518
Current: ILA 2,490
Upside: +81.46%
Ligand Pharmaceuticals
Jul 16, 2026
Reiterated: Buy
Price Target: $220 → $335
Current: $288.05
Upside: +16.30%
Repligen
Jul 7, 2026
Upgraded: Buy
Price Target: $185
Current: $165.05
Upside: +12.09%
Proto Labs
Jul 6, 2026
Reiterated: Buy
Price Target: $91
Current: $80.89
Upside: +12.50%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $72.25
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $125.86
Upside: -24.52%
Halozyme Therapeutics
Feb 19, 2026
Reiterated: Buy
Price Target: $90
Current: $107.39
Upside: -16.19%
Codexis
Nov 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.43
Upside: -
OmniAb
Nov 6, 2025
Reiterated: Buy
Price Target: $6 → $4
Current: $4.02
Upside: -0.37%
Oct 31, 2025
Reiterated: Buy
Price Target: $38
Current: $4.02
Upside: +832.84%
Aug 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.05
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $5
Current: $4.52
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $12
Current: $5.68
Upside: n/a
Jul 31, 2025
Reiterated: Buy
Price Target: $3
Current: $1.29
Upside: n/a
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $4.50
Upside: n/a
Oct 26, 2023
Reiterated: Hold
Price Target: n/a
Current: $605.69
Upside: n/a
Oct 25, 2023
Reiterated: Hold
Price Target: n/a
Current: $204.85
Upside: n/a
Sep 15, 2023
Reiterated: Hold
Price Target: n/a
Current: $5.01
Upside: n/a
Apr 4, 2023
Reiterated: Buy
Price Target: $9 → $80
Current: $1.99
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $2.63
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.54
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $3.64
Upside: n/a
Oct 17, 2018
Initiated Coverage: Buy
Price Target: $4.2
Current: $6.50
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $0.7998
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: $2.4
Current: $2.14
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $0.93045
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $6.86
Upside: n/a